Data on importance of hematopoietic cell derived Lipocalin 2 against gut inflammation  by Saha, Piu et al.
Contents lists available at ScienceDirect
Data in Brief
Data in Brief 8 (2016) 812–816http://d
2352-34
(http://c
n Corr
United
E-mjournal homepage: www.elsevier.com/locate/dibData ArticleData on importance of hematopoietic cell derived
Lipocalin 2 against gut inﬂammation
Piu Saha a, Vishal Singh a, Xia Xiao a, Beng San Yeoh a,
Matam Vijay-Kumar a,b,n
a Department of Nutritional Sciences, The Pennsylvania State University, University Park, PA 16802,
United States
b Department of Medicine, The Pennsylvania State University Medical Center, Hershey, PA 17033,
United Statesa r t i c l e i n f o
Article history:
Received 25 May 2016
Received in revised form
13 June 2016
Accepted 27 June 2016
Available online 2 July 2016
Keywords:
Siderocalin
Gut microbiota
Inﬂammatory bowel disease
Bone marrow chimeras
Colitisx.doi.org/10.1016/j.dib.2016.06.047
09/& 2016 The Authors. Published by Else
reativecommons.org/licenses/by/4.0/).
esponding author at: Department of Nutriti
States. Fax: þ1 814 863 6103.
ail address: mvk13@psu.edu (M. Vijay-Kuma b s t r a c t
The data herein is related to the research article entitled “Micro-
biota-inducible innate immune siderophore binding protein Lipo-
calin 2 is critical for intestinal homeostasis” (Singh et al., 2016) [1].
In the present article, we monitored dextran sodium sulfate (DSS)-
induced colitis development upon Lipocalin 2 (Lcn2) neutraliza-
tion, and examined the survival of Lcn2 deﬁcient (Lcn2KO) mice
and their WT littermates upon DSS challenge. To dissect the rela-
tive contribution of immune and non-immune cells-derived Lcn2
in mediating protection against gut inﬂammation, we generated
respective bone marrow chimera and evaluated their susceptibility
to IL-10 receptor neutralization-induced chronic colitis.
Neutralization of Lcn2 in WT mice resulted in exacerbated DSS-
induced colitis. Notably, mice lacking Lcn2 exhibited 100% mor-
tality whereas only 20% mortality was observed in WT mice upon
DSS challenge. Further, data from bone marrow chimera showed
that immune cell-derived Lcn2 is the major contributor in con-
ferring protection against colitis.
& 2016 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).vier Inc. This is an open access article under the CC BY license
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ow data was
acquiredAssessment of colitis parameters, percent survival, myeloperoxidase assay,
enzyme linked immunosorbent assay (ELISA), Biotek Eon™ microplate
spectrophotometer.ata format Analyzed
xperimental
factorsThe susceptibility to DSS-induced colitis was assessed in Lcn2KO mice and
their WT littermates. Lcn2 bone marrow chimeras was generated and eval-
uated for susceptibility to IL-10 receptor neutralization-induced chronic
colitis.xperimental
featuresPercent survival and analysis of standard colitis parametersata source location Pennsylvania, USA
ata accessibility Data are provided with this articleDValue of the data The data are valuable to researchers interested in investigating the role of Lcn2 in inﬂammatory
bowel disease.
 The data provide information on protective roles of immune vs non-immune cell derived Lcn2
during gut inﬂammation.
 The data support future studies in delineating the role of Lcn2 in mucoprotection.1. Data
In the data, we presented the higher mortality rate of Lcn2KO mice in DSS-induced acute colitis when
compared to their WT littermates (Fig. 1). Further, neutralization of Lcn2 in DSS-treated WT mice resultedbility of Lcn2KO mice to DSS-induced acute colitis. (A) Percent body weight loss of DSS-treated
littermates (n¼5). (B) Percent survival of WT and Lcn2KO mice upon challenge with 1.5% DSS for
ssed as mean7SEM. One-way analysis of variance with the Tukey multiple comparison test were
ed statistically signiﬁcant.
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and serum KC (Fig. 2). Experiments with bone marrow chimeric mice revealed that immune cells-derived
Lcn2 are the major contributor in mediating protection against IL-10R neutralization-induced chronic colitis
(Fig. 3) indicated by reduction in splenomegaly, colomegaly, shrunken ceca, MPO protein levels and activity.2. Experimental design, materials and methods
2.1. DSS induced mortality
Eight weeks old female C57BL/6 WT and Lcn2KO mice (n¼5) were administered 1.5% DSS (MP
Biomedicals Inc.) in drinking water for 7 days. Colonic inﬂammation was examined by fecal occult
blood, diarrhea, and loss of body weight. After 7 days, mice were switched to regular drinking and
subsequently monitored for mortality up to 21 days.Fig. 2. Data on effect of Lcn2-neutralization on severity of colitis. WT mice (female, 8 weeks old, n¼5) were administered 1.5%
DSS for 7 days. On day 3 onwards up to day 7, colitic mice were administered once/day with either anti-mouse Lcn2 mAb
(mLcn2, 20 mg/mouse/day, intraperitoneally) or isotype antibody (IgG1). After 7 days, mice were euthanized and analyzed for
standard colitis parameters. (A) Body weight, (B) spleen weight, (C) colon thickening and (D) serum KC. Data are expressed as
mean7SEM. Unpaired t-test was used to compare the difference between groups. *po0.05 was considered statistically
signiﬁcant.
Fig. 3. Contribution of immune and non-immune cells derived Lcn2 on the severity of colitis in Lcn2 bone marrow chimeric
mice. To explore the relative contribution of immune and non-immune cells-derived Lcn2 in severity of colitis, Lcn2 bone
marrow chimeric mice were treated with IL-10R-neutralizing antibody (1.0 mg/mouse, intraperitoneally, once/week) for
4 weeks (n¼4). One week after the fourth injection, mice were euthanized and analyzed for standard colitis parameters.
(A) Gross picture of colon and spleen, (B) spleen weight, (C) colon weight, (D) cecum weight, (E) serum MPO, (F) colonic MPO
protein level and (G) colonic MPO activity. The constitution of the bone marrow chimeric mice is denoted as (BM donors) –
(recipient mice) accordingly. Data are expressed as mean7SEM. Unpaired t-test was used. *po0.05 was considered statisti-
cally signiﬁcant.
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Female WT mice (8 weeks old; n¼5) were administered 1.5% DSS in drinking water for 7 days. On
day 3 onwards up to day 7, mice were administered once daily with anti-mouse Lcn2 monoclonal
antibody (20 mg/mouse/day, intraperitoneally; R&D Systems). Control mice received isotype (IgG1)
control. On day 7, mice were euthanized by CO2 asphyxiation and blood samples were collected in a
serum separating tube (Becton Dickinson). Upon centrifugation, the hemolysis-free serum were
collected and stored at 80 °C until further analysis. Standard colitis parameters (body weight, spleen
weight, occult blood and colon shortening) were assessed. Serum KC were analyzed by ELISA
according to the manufacturer's protocol [2].
2.3. Bone marrow chimera generation and neutralization of IL-10R
Eight weeks old Lcn2KO mice and their WT littermates were employed to generate WT-WT,
WT-Lcn2KO, Lcn2KO-WT, and Lcn2KO-Lcn2KO bone marrow chimeras (BMC; denoted as bone
marrow donor-recipients) as described previously [1]. 95–99% chimerism was conﬁrmed by
P. Saha et al. / Data in Brief 8 (2016) 812–816816determining the differential CD45.1 and CD45.2 expression in PBMC of recipient mice via ﬂow
cytometry [3,4].
After 8 weeks post-transplant, Lcn2 bone marrow chimeric mice (n¼4) were administered anti-
mouse α-IL10R mAb (1.0 mg/mouse, intraperitoneally; BioXcell) once weekly for total of 4 weeks to
induce chronic colitis as described earlier [1]. Control mice received isotype (IgG1) control. Mice were
regularly monitored for fecal occult blood and change in body weight. One week after the fourth
injection, the mice were euthanized and analyzed for standard colitis parameters [5]. MPO levels in
the serum and colon lysate were measured by ELISA according to the manufacturer's protocol.
2.4. Statistical analysis
Data are expressed as mean7SEM. The signiﬁcance of difference between two groups was
determined by unpaired student t-test. The statistical signiﬁcance between 3 or more groups were
analyzed by one-way ANOVA with Tukey's post-hoc test. p value less than 0.05 were considered
statistically signiﬁcant. Statistical signiﬁcance was calculated using Graph Pad Prism version 6.0
(Graph Pad Software Inc.).Acknowledgments
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